Comment
Author: Admin | 2025-04-28
IV" (PDF). Isomer Design. Drug Enforcement Administration. Archived (PDF) from the original on March 3, 2022. Retrieved January 16, 2023.^ Mullen, Jr., Francis M. (December 28, 1982). "Schedules of Controlled Substances; Placement of Triazolam into Schedule IV" (PDF). Isomer Design. Drug Enforcement Administration. Archived (PDF) from the original on March 3, 2022. Retrieved January 16, 2023.^ Marshall, Donnie (September 15, 1999). "Schedules of Controlled Substances; Placement of Zaleplon into Schedule IV". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.^ Bonner, Robert (February 5, 1993). "Schedules of Controlled Substances; Placement of Zolpidem into Schedule IV" (PDF). Isomer Design. Drug Enforcement Administration. Archived from the original (PDF) on March 3, 2022. Retrieved January 16, 2023.^ Leonhart, Michele (April 4, 2005). "Schedules of Controlled Substances: Placement of Zopiclone Into Schedule IV". Federal Register. Drug Enforcement Administration.^ Milgram, Anne (October 31, 2023). "Schedules of Controlled Substances: Placement of Zuranolone in Schedule IV". Federal Register. Drug Enforcement Administration. Retrieved November 3, 2023.^ Leonhart, Michele (May 8, 2013). "Schedules of Controlled Substances: Placement of Lorcaserin Into Schedule IV". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.^ a b c d Lawn, John (May 17, 1988). "Schedules of Controlled Substances; Temporary Placement of Cathine ((+ )-norpseudoephedrine), Fencamfamin, Fenproporex and Mefenorex Into Schedule IV" (PDF). Isomer Design. Drug Enforcement Administration. Archived from the original (PDF) on March 3, 2022. Retrieved January 16, 2023.^ a b Ingersoll, John (July 6, 1973). "Diethylpropion and Phentermine; Temporary Placement in Schedule IV" (PDF). Isomer Design. Bureau of Narcotics and Dangerous Drugs. Archived (PDF) from the original on March 3, 2022. Retrieved January 16, 2023.^ Mullen, Jr., Francis M. (October 27, 1981). "Rescheduling of Mazindol into Schedule IV" (PDF). Isomer Design. Drug Enforcement Administration. Archived (PDF) from the original on September 26, 2021. Retrieved January 16, 2023.^ Marshall, Donnie (January 27, 1999). "Schedules of Controlled Substances: Placement of Modafinil Into Schedule IV". Federal Register. Drug Enforcement Administration.^ Bartels, Jr., John R. (January 28, 1975). "Placement of Pemoline in Schedule IV" (PDF). Isomer Design. Drug Enforcement Administration. Archived (PDF) from the original on March 3, 2022. Retrieved January 16, 2023.^ a b Bensinger, Peter (September 30, 1980). "Pipradrol and SPA in Schedule IV" (PDF). Isomer Design. Drug Enforcement Administration. Archived (PDF) from the original on March 3, 2022. Retrieved January 16, 2023.^ Milgram, Anne (July 25, 2022). "Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV". Federal Register. Drug Enforcement Administration. Retrieved September 6, 2023.^ Gruden, Peter (February 11, 1998). "Schedules of Controlled Substances: Placement of Sibutramine Into Schedule IV". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.^ Dhillon, Uttam (January 7, 2020). "Schedules of Controlled Substances: Placement of Solriamfetol in Schedule IV". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.^ Bensinger, Peter (February 9, 1979). "Placement of Pentazocine into Schedule IV" (PDF). Isomer Design. Drug Enforcement Administration. Archived (PDF) from the original on March 3, 2022. Retrieved January 16, 2023.^ Milford, Jr., James S. (October 31, 1997). "Schedules of Controlled Substances Placement of Butorphanol Into Schedule IV". Federal
Add Comment